Covered recipient · General Payments record
CRYSTAL R WHITBY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$3,440.79
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $380.74 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $189.58 | 10 |
| Janssen Biotech, Inc. | $41.66 | 2 |
| Galderma Laboratories, L.P. | $38.89 | 2 |
| E.R. Squibb & Sons, L.L.C. | $34.05 | 2 |
| Incyte Corporation | $28.21 | 1 |
| Lilly USA, LLC | $24.52 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.80 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402219 | CMS |
| ABBVIE INC. | $32.46 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402221 | CMS |
| ABBVIE INC. | $23.08 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402223 | CMS |
| ABBVIE INC. | $10.78 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402225 | CMS |
| ABBVIE INC. | $9.67 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402227 | CMS |
| ABBVIE INC. | $18.75 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402229 | CMS |
| ABBVIE INC. | $8.39 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402231 | CMS |
| ABBVIE INC. | $24.95 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402233 | CMS |
| ABBVIE INC. | $22.04 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402235 | CMS |
| ABBVIE INC. | $29.66 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108402237 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.72 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101734670 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101734779 | CMS |
| Galderma Laboratories, L.P. | $23.50 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400535 | CMS |
| Galderma Laboratories, L.P. | $15.39 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400537 | CMS |
| Incyte Corporation | $28.21 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141299617 | CMS |
| Janssen Biotech, Inc. | $16.14 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078720700 | CMS |
| Janssen Biotech, Inc. | $25.52 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078720923 | CMS |
| Lilly USA, LLC | $24.52 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135546907 | CMS |
| Novartis Pharmaceuticals Corporation | $23.83 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087411526 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.